1 / 11

Gastrointestinal stromal tumour of Stomach

Gastrointestinal stromal tumour of Stomach. 50% occur in stomach, constitutes 1-3% of all gastric neoplasia Previously mistaken for leiomyoma or leiomyosarcoma They are arise of mesenchymal origin, from the interstitial (pacemaker) cells of Cajal .

efia
Download Presentation

Gastrointestinal stromal tumour of Stomach

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Gastrointestinal stromal tumourof Stomach

  2. 50% occur in stomach, constitutes 1-3% of all gastric neoplasia • Previously mistaken for leiomyoma or leiomyosarcoma • They are arise of mesenchymalorigin, from the interstitial (pacemaker) cells of Cajal. • Associated with mutation in the tyrosine kinase c-kit oncogene. • Equal incidence in males and females

  3. Biological behavior is unpredictable. Size >5cm and mitotic index are predictors of metastasis. • May spread to liver, peritoneum. Lymph nodal spread is rare

  4. May be small and asymptomatic. • May ulcerate and cause bleeding • Large tumors may present like gastric cancers • Endoscopic biopsy useful in only ulcerated tumours. • Endoscopic usg and targeted biopsy may be successful in getting a representative tissue for diagnosis. • CT scan-

  5. Surgical resection with tumour free margins is the best line of treatment. Wedge local excision, gastrectomy usually without lymphadenectomy. • Large tumours with extensive local spread/ metastasis are treated by imatinib which is a tyrosine kinase inhibitor, for 3-6 months pre-operatively. Liver metastasis can be resected. • Large, metastatic tumours will require life long imatinib therapy post- operatively. • Sunitinib for patients with imatinibresistenttumours

  6. Gastric Lymphomas • Primary or gastric involvement of a generalised lymphoma • Primary Gastric lymphoma forms about 5% of all gastric neoplasms • Common in 6th decade of life. May be due to H.pylori. • Clinical features- similar to carcinoma of stomach. Pain abdomen, weight loss, bleeding • B cell in origin, arise from the mucosa associated lymphoid tissue. They are confined to stomach and lymph node spread occurs after a long time

  7. Endoscopy- early stages- diffuse mucosal thickening, mucosal ulceration. Biopsy to confirm the diagnosis. • Investigations- CT scan of abdomen and chest, bone marrow study to find out if it is primary gastric lymphoma or a part of generalised lymphoma. Complete blood count. • Treatment- may respond to H. pylori eradication. Primary gastric lymphoma is best treated by gastrectomy. Can also be treated by chemotherapy- particularly if distant spread is present

  8. Diffuse lymphoma involving stomach- treated by chemotherapy. Surgery is indicated only if there is gastric perforation or gastric bleed and may need gastrectomy.

More Related